Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Sodium oxybate for the treatment of fibromyalgia.

Staud R.

Expert Opin Pharmacother. 2011 Aug;12(11):1789-98. doi: 10.1517/14656566.2011.589836. Epub 2011 Jun 16. Review.

PMID:
21679091
2.

Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study.

Russell IJ, Holman AJ, Swick TJ, Alvarez-Horine S, Wang YG, Guinta D; Sodium Oxybate 06-008 FM Study Group.

Pain. 2011 May;152(5):1007-17. doi: 10.1016/j.pain.2010.12.022. Epub 2011 Mar 11.

PMID:
21397402
3.

Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial.

Spaeth M, Bennett RM, Benson BA, Wang YG, Lai C, Choy EH.

Ann Rheum Dis. 2012 Jun;71(6):935-42. doi: 10.1136/annrheumdis-2011-200418. Epub 2012 Jan 31.

4.

gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.

Pardi D, Black J.

CNS Drugs. 2006;20(12):993-1018. Review.

PMID:
17140279
5.

Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study.

Moldofsky H, Inhaber NH, Guinta DR, Alvarez-Horine SB.

J Rheumatol. 2010 Oct;37(10):2156-66. doi: 10.3899/jrheum.091041. Epub 2010 Aug 3.

7.

Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia.

Spaeth M, Alegre C, Perrot S, Wang Y, Guinta DR, Alvarez-Horine S, Russell I; Sodium Oxybate Fibromyalgia Study Group.

Arthritis Res Ther. 2013 Nov 11;15(6):R185. doi: 10.1186/ar4375.

8.

The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.

Scharf MB, Baumann M, Berkowitz DV.

J Rheumatol. 2003 May;30(5):1070-4.

PMID:
12734908
9.

Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls.

Donjacour CE, Aziz NA, Roelfsema F, Frölich M, Overeem S, Lammers GJ, Pijl H.

Am J Physiol Endocrinol Metab. 2011 Jun;300(6):E1069-75. doi: 10.1152/ajpendo.00623.2010. Epub 2011 Mar 29. Erratum in: Am J Physiol Endocrinol Metab. 2011 Aug;301(2):E426.

10.

A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome.

George CF, Feldman N, Zheng Y, Steininger TL, Grzeschik SM, Lai C, Inhaber N.

Sleep Breath. 2011 Jan;15(1):13-20. doi: 10.1007/s11325-009-0320-0. Epub 2010 Jan 18.

11.

Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing.

Feldman NT.

Sleep Breath. 2010 Feb;14(1):77-9. doi: 10.1007/s11325-009-0283-1. Epub 2009 Jul 23. Review.

12.

The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.

Black J, Pardi D, Hornfeldt CS, Inhaber N.

Sleep Med. 2009 Sep;10(8):829-35. doi: 10.1016/j.sleep.2009.05.004. Epub 2009 Jul 18.

PMID:
19616998
13.

Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report.

Scharf MB, Hauck M, Stover R, McDannold M, Berkowitz D.

J Rheumatol. 1998 Oct;25(10):1986-90.

PMID:
9779855
14.

Sodium oxybate: a potential new pharmacological option for the treatment of fibromyalgia syndrome.

Swick TJ.

Ther Adv Musculoskelet Dis. 2011 Aug;3(4):167-78. doi: 10.1177/1759720X11411599.

15.

Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.

[No authors listed]

Prescrire Int. 2007 Jun;16(89):98-101.

PMID:
17582923
16.

Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.

Russell IJ, Perkins AT, Michalek JE; Oxybate SXB-26 Fibromyalgia Syndrome Study Group.

Arthritis Rheum. 2009 Jan;60(1):299-309. doi: 10.1002/art.24142.

17.

A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy.

Mamelak M, Swick T, Emsellem H, Montplaisir J, Lai C, Black J.

Sleep Med. 2015 Jan;16(1):52-8. doi: 10.1016/j.sleep.2014.10.004. Epub 2014 Oct 22.

18.

A review of sodium oxybate and baclofen in the treatment of sleep disorders.

Brown MA, Guilleminault C.

Curr Pharm Des. 2011;17(15):1430-5. Review.

PMID:
21476957
19.

Sodium oxybate: efficacy, safety and tolerability in the treatment of narcolepsy with or without cataplexy.

Owen RT.

Drugs Today (Barc). 2008 Mar;44(3):197-204. doi: 10.1358/dot.2008.44.3.1162240. Review.

PMID:
18536781
20.

The use of sodium oxybate to treat narcolepsy.

Mayer G.

Expert Rev Neurother. 2012 May;12(5):519-29. doi: 10.1586/ern.12.42. Review.

PMID:
22550980

Supplemental Content

Support Center